Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
NCT01040624
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
77
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
RADIATION:
< 15% risk of + LN
RADIATION:
> 15% risk of + LN
Sponsor
University of Florida